HLA transgenic mice as humanized mouse models of disease and immunity

Journal of Clinical Investigation

Volumn 101, Issue 5, 1998, Pages 921-926

  Taneja, Veena ^a   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; AUTOIMMUNE DISEASE; HASHIMOTO DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINE PRODUCTION;

EID: 0032032959     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2860     Document Type: Review

References (40)

1. Hammer, R.E., S.D. Maika, J.A. Richardson, J.P. Tang, and J.D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human βm: an animal model of HLA-B27 associated human disorders. Cell. 63:1099-1112.
2. Khare, S.D., H.S. Luthra, and C.S. David. 1995. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin. A model of human spondyloarthropathies. J. Exp. Med. 182:1153-1158.
3. Khare, S.D., J. Hansen, H.S. Luthra, and C.S. David. 1990. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human β2-microglobulin (β2m) double transgenic mice with disrupted mouse β2m. J. Clin. Invest. 98:2746-2755.
4. Lawrance, S.K., L. Karlsson, J. Price, V. Quaranta, Y. Ron, J. Sprent,and P.A. Peterson. 1989. Transgenic HLA-DRα faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to Eα in Eα○ mutant mice. Cell. 58:583-594.
5. Zhou, P., G.D. Andersen, S. Savarirayan, H. Inoko, and C.S. David. 1991. Thymic deletion of Vb11+ and Vb5+ T cells in H-2E negative HLA-DQb+ single transgenic mouse. J. Immunol. 146:854-859.
6. Zhou, P., M.K. Smart, S. Cheng, S. Savarirayan, H. Inoko, and C.S. David. 1992. HLA-DQb chain can present mouse endogenous provirus MTV-9 product and clonally delete Tcr Vb5+ and Vb11 + T cells in transgenic mice. Immunogenetics. 35:219-223.
7. Straub, G., D.A.A. Vignali, G. Schonrich, and G.J. Hammerling. 1994. Negative and positive selection by HLA-DR3 (Drw17) molecules in transgenic mice. Immunogenetics. 40:104-108.
8. Nishimura, Y., T. Iwanaga. T. Inamitsu. Y. Yanagawa. M. Yasunami, A. Kimura, K. Hirokawa, and T. Sasazuki. 1990. Expression of the human MHC. HLA-DQW6 genes alters the immune response in C57BL/6 mice. J. Immunol. 145:353-360.
9. Cammarota, G., A. Scheirie. B. Takacs, D.M. Doran, R. Knorr. W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature. 356:799-801.
10. Vignali, D.A.A., J. Moreno, D. Schiller, and G.J. Hammerling. 1992. Species specific binding of CD4 to the β2 domain of major histocompatibility complex class II molecules. J. Exp. Med. 175:925-932.
11. Altmann, D.M., D.C. Douek, A.J. Frater, C.M. Hetherington. H. Inoko. and J.I. Elliot. 1994. The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J. Exp. Med. 181:867-875.
12. Yammaoto, K., Y. Fukui, Y. Esaki. T. Inamitsu. T. Sudo, K. Yamane, N. Kamikawaji, A, Kimura, and T. Sasazuki. 1994. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice. J. Exp. Med. 180:165-171.
13. Fugger, L., S.A. Michie, I. Rulifson, C.B. Lock, and G.S. McDevitt. 1994. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T cell repertoire and mediates an HLA-DR restricted immune response. Proc. Natl. Acad. Sci. USA. 91:6151-6155.
14. Yeung, R.S.M., J.M. Penninger, T.M. Kundig, Y. Law, K. Yammamoto, N. Kamikawaji, L. Burkly. T. Sasazuki, R. Flavell, P.S. Ohashi, and T. W. Mak. 1994. Human CD4-major histocompatibility complex class H (DQW6) transgenic mice in an endogenous CD4/CD8-deticient background: reconstitution of phenotype and human-restricted function. J. Exp. Med. 180:1911-1920.
15. Woods, A., H.Y. Chen, M.E. Trumbauer, A. Sirotina, R. Cummings, and D.M. Zaller. 1994. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J. Exp. Med. 180:173-181.
16. Gosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur. C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell. 66:1051-1066.
17. Cheng, S., J. Baisch, C. Krco, S. Savarirayan, J. Hanson, K. Hodgson, M. Smart, and C.S. David. 1996. Expression and function of HLA-DQ8 (DOA1*0301/DOB1*0302) genes in transgenic mice. Eur. J. Immunogenetics. 23:15-20.
18. Nabozny, G.H., J.M. Baisch, S. Cheng, D. Cossgrove. M.M. Griffiths, H.S. Luthra, and C.S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen induced arthritis. A novel model for human polyarthritis. J. Exp. Med. 183:27-37.
19. Gonzalez-Gay, M.A., G.H. Nabozny, M.J. Bull, E. Zanelli, J. Douhan III. M.M. Griffiths. L.H. Glimcher, H.S. Luthra, and C.S. David. 1994. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J. Exp. Med. 180:1559-1564.
20. Gonzalez-Gay, M.A., E. Zanelli, C.J. Krco, G.H. Nabozny, J. Hanson, M.M. Griffiths, H.S. Luthra, and C.S. David. 1995. Polymorphism of the MHC class II Eb gene determines the protection against collagen induced arthritis. Immunogenetics. 42:35-41.
21. Zanelli, E., M.A. Gonzalez-Gay, and C.S. David. 1995. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immumol. Today. 16: 274-278.
22. Zanelli, E., C.J. Krco, J.M. Baisch, S. Cheng, and C.S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hyper-variable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Aacd. Sci. USA. 93:1814-1819.
23. Matsushita, S., T. Nishi, M. Oiso, K. Yamaoka, K. Yone, T. Kanai, and Y. Nishimura. 1996. HLA-DQ binding motifs. Comparative analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int. Immunol. 8:757-764.
24. Zanelli, E., C.J. Krco, and C.S. David. 1997. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J. Immunol. 158:3545-3551.
25. Bradley, D.S., G.H. Nabozny, S. Cheng, P. Zhou. M.M. Griffiths, H.S. Luthra, and C.S. David. 1997. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100:2227-2234.
26. Taneja, V., J. Hanson, M.K. Smart, M.M. Griffiths, H.S. Luthra, and C.S. David. 1997. Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int. Immunol. 9:1213-1219.
27. Gonzalez-Gay, M.A., E. Zanelli, S.D. Khare, C.J. Krco, P. Zhou, H. Inoko, M.M. Griffiths, H.S. Luthra, and C.S. David. 1996. Human leukocyte antigen-DRB1*1502 (DR2DW12) Iransgene reduces incidence and severity of arthritis in mice. Hum. Immunol. 50:54-60.
28. Taneja, V., J. Hanson, M. Smart, M.M. Griffiths, H. Luthra, and C.S. David. 1996. HLA-DRB1 polymorphism mediates protection to collagen induced arthritis: implications in rheumatoid arthritis. Arthritis Rheum. 39:S31. (Abstr.)
29. Rosloniec, E.F., D.D. Brand, L.K. Myers, K.B. Whittington, M. Gumanovskaya, D.M. Zaller, A. Woods, D.M. Altmann, J.M. Stuart, and A.H. Kang. 1997. An HLA-DR1 transgene confers susceptibility to collagen induced arthritis elicited with human type II collagen. J. Exp. Med. 185:1113-1123.
30. Kong, Y.M., L.C. Lomo, R.W. Motte. A.A. Giraldo. J. Baisch, S. Gudrun, G.J. Hammerling, and C.S. David. 1996. HLA-DRB1 polymorphism delermines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med 184:1167-1172.
31. Fukui, Y., Y. Nishimura, T. Iwanga, A. Kimura. T. Inamitsu. Y. Hanaoka, T. Kitigawa, and T. Sasazuki. 1989. Glycosuria and insulitis in NOD mice expressing the HLA-DQW6 molecule. J. Immunogenenetics. 16:445-453.
32. Wicken, L.S., S.L. Chen, G.T. Nepom, J.F. Elliot. D.C. Freed, A. Bansal. S. Zheng, A. Herman, A. Lernmark, D.M. Zaller, et al. 1996. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J. Clin. Invest. 98:2597-2603.
33. Patel, S.D., A.P. Cope, M. Congia. T.T. Chen. E. Kim, L. Fugger, D. Wherrett, and G.S. McDevitt. 1997. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR (alpha*0101, beta*0401) transgenic mice. Proc. Natl. Acad. Sci. USA. 94:8082-8087.
34. RaJu, R., S.R. Munn, and C.S. David. 1997. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum. Immunnol. 88:21-29.
35. Ito, K., H.J. Bian, M. Molina, J. Han, J. Magram, E. Saar, C. Belunis, D.R. Bolin, R. Arceo, R. Campbell, et al. 1996. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183:2635-2644.
36. Das, P., K. Drescher, D.S. Bradley, C. Reviera-Quinones, M. Rodriguez, and C.S. David. 1997. HLA transgenic mice as humanized models of multiple sclerosis (MS): studies on EAE. Hum. Immunol. 55(SuppI. 1 ):4. (Abstr.)
37. Bagavant, H., F.M. Fusi, J. Baisch, B. Kurth, C.S. David, and K.S.K. Tung. 1997. Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine. Biol. Reprod. 56:764-770.
38. Geluk, A., V. Taneja, K.E. van Meijgaarlen, E. Zanelli, R.R.P. de Vries, C.S. David, and T.H.M. Ottenhoff. 1997. T cell responses to mycobacterial antigen in HLA-DR3 transgenic mice. In Tolerance and Autoimmunity. Proceedings of the 25th Keystone Symposium. T.W. Mak, H. Wgzell, and I. Weissman, editors. 15.
39. Neeno, T., C.J. Krco, J. Marders, J. Baisch, S. Cheng, and C.S. David. 1996. HLA-DQ8 transgenic mice lacking endogenous class II molecules respond to house dust allergens. J. Immunol. 156:3191-3195.
40. Svetlana, S.P., C.J. Krco, J. Marders, and C.S. David. 1997. HLA-DQ6 and HLA-DQ8 transgenic mice respond to Ryegrass allergen and recognize different epitopes on its major antigen. Hum. Immunol. 55(Suppl. 1):24. (Abstr.)